Inhibition of intestinal glucose absorption by anti-diabetic medicinal plants derived from the James Bay Cree traditional pharmacopeia

Journal of Ethnopharmacology

Volumn 132, Issue 2, 2010, Pages 473-482

  Nistor Baldea, Lidia A ^a,b,c   Martineau, Louis C ^a,b   Benhaddou Andaloussi, Ali ^a,b   Arnason, John T ^b,d   Lévy, Émile ^c   Haddad, Pierre S ^a,b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CIHR Team in Aboriginal Anti Diabetic Medicines ^*  (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Aboriginal populations; Caco 2 15 cells; GLUT2; Natural health products; SGLT1; Type 2 diabetes

Indexed keywords

ABIES BALSAMEA EXTRACT; ALNUS INCANA EXTRACT; ANTIDIABETIC AGENT; DEOXYGLUCOSE; GAULTHERIA HISPIDULA EXTRACT; GLUCOSE; GLUCOSE TRANSPORTER 2; JUNIPERUS COMMUNIS EXTRACT; KALMIA ANGUSTIFOLIA EXTRACT; LARIX LARICINIA EXTRACT; LYCOPODIUM CLAVATUM EXTRACT; PHLORIZIN; PICEA GLAUCA EXTRACT; PICEA MARIANA EXTRACT; PINUS BANKSIANA EXTRACT; PLANT EXTRACT; POPULUS BALSAMIFERA EXTRACT; RHODODENDRON GROENLANDICUM EXTRACT; RHODODENDRON TOMENTOSUM EXTRACT; SALIX PLANIFOLIA EXTRACT; SARRACENIA PURPUREA EXTRACT; SODIUM GLUCOSE COTRANSPORTER 1; SORBUS DECORA EXTRACT; UNCLASSIFIED DRUG; VACCINIUM VITIS EXTRACT;

ABIES BALSAMEA; ABORIGINE; ALNUS INCANA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLACK SPRUCE; CANADA; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; GAULTHERIA HISPIDULA; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; JUNIPERUS; KALMIA ANGUSTIFOLIA; LARIX LARICINIA; LYCOPODIUM; MALE; MEDICAL LITERATURE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PINUS BANKSIANA; POPULUS BALSAMIFERA; PROTEIN EXPRESSION; RAT; RHODODENDRON GROENLANDICUM; RHODODENDRON TOMENTOSUM; SALIX PLANIFOLIA; SARRACENIA PURPUREA; SORBUS DECORA; STOMACH LAVAGE; TAIGA; VACCINIUM VITIS; WHITE SPRUCE;

ANIMALS; CACO-2 CELLS; CANADA; DIABETES MELLITUS, TYPE 2; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 2; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INDIANS, NORTH AMERICAN; INTESTINAL ABSORPTION; MALE; PHARMACOPOEIAS AS TOPIC; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; SODIUM-GLUCOSE TRANSPORTER 1;

RATTUS;

EID: 78049358298     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.07.055     Document Type: Article

References (54)

1. Alvarado F.C., Crane R.K. Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine in vitro. Biochimica Biophysica Acta 1962, 56:170-172.
2. Bissonnette P., Gagné H., Blais A., Berteloot A. 2-Deoxyglucose transport and metabolism in Caco-2 cells. American Journal of Physiology 1996, 270:G153-162.
3. Bonadonna R.C. Alterations of glucose metabolism in type 2 diabetes mellitus. An overview. Reviews in Endocrine and Metabolic Disorders 2004, 5:89-97.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
5. Burcelin R., Eddouks M., Kande J., Assan R., Girard J. Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinaemia and increased by hyperglycaemia in liver of diabetic rats. Biochemical Journal 1992, 288:675-679.
6. Burnette W.N. Western Blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Analytical Biochemistry 1981, 112:195-203.
7. Campbell M.L., Diamant R.M.F., MacPherson B.D., Grunau M., Halladay J. Energy and nutrient intakes of men (56-74 years) and women (16-74 years) in three northern Manitoba Cree communities. Journal of the Canadian Dietetic Association 1994, 55:167-174.
8. Castaneda F., Burse A., Boland W., Kinne R.K.H. Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes. International Journal of Medical Sciences 2007, 4:131-139.
9. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 2005, 54:1-7.
10. Day A.J., Bao Y.P., Morgan M.R.A., Williamson G. Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology and Medicine 2000, 29:1234-1243.
11. Decker T., Lohmann-Matthes M.L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. Journal of Immunological Methods 1988, 15:61-69.
12. DeJonge P.C., Wieringa T., Van Putten J.P., Krans H.M., Van Dam K. Phloretin-an uncoupler and an inhibitor of mitochondrial oxidative phosphorylation. Biochimica Biophysica Acta 1983, 722:219-225.
13. Delie F., Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Critical Reviews in Therapeutic Drug Carrier Systems 1997, 14:221-286.
14. Drozdowski L.A., Thompson A.B.R. Intestinal sugar transport. World Journal of Gastroenterology 2006, 12:1657-1670.
15. Dyer J., Hosie K.B., Shirazi-Beechey S.P. Nutrient regulation of human intestinal sugar transporter (SGLT1) expression. Gut 1997, 41:56-59.
16. Dyer J., Wood I.S., Palejwala A., Ellis A., Shirazi-Beechey S.P. Expression of monosaccharide transporters in intestine of diabetic humans. American Journal of Physiology - Gastrointestinal and Liver Physiology 2002, 282:G241-G248.
17. Ehrenkranz J.R., Lewis N.G., Kahn C.R., Roth J. Phlorizin: a review. Diabetes/Metabolism Research and Reviews 2005, 21:31-38.
18. Fedorak R.N., Cheeseman C.I., Thomson A.B., Porter V.M. Altered glucose carrier expression: mechanism of intestinal adaptation during streptozocin-induced diabetes in rats. American Journal of Physiology - Gastrointestinal and Liver Physiology 1991, 261:G585-G591.
19. Fraser M.H., Cuerrier A., Haddad P.S., Arnason J.T., Owen P.L., Johns T. Medicinal plants of Cree communities (Quebec, Canada): antioxidant activity of plants used to treat type 2 diabetes symptoms. Canadian Journal of Physiology and Pharmacology 2007, 85:1200-1214.
20. Grover J.K., Yadav S., Vats V. Medicinal plants of India with anti-diabetic potential. Journal of Ethnopharmacology 2002, 81:81-100.
21. Haffner S.J., Cassells H. Hyperglycemia as a cardiovascular risk factor. The American Journal of Medicine 2003, 115:6S-11S.
22. Hamman R.F. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes/Metabolism Research and Reviews 1992, 8:287-338.
23. Hanamura T., Mayama C., Aoki H., Hirayama Y., Shimizu M. Antihyperglycemic Effect of Polyphenols from Acerola (Malpighia emarginata DC.) fruit. Bioscience, Biotechnology, and Biochemistry 2006, 70:1813-1820.
24. Harbilas D., Martineau L.C., Harris C.S., Adeyiwola-Spoor D.C.A., Saleem A., Lambert J., Caves D., Johns T., Prentki M., Cuerrier A., Arnason J.T., Bennett S.A.L., Haddad P.S. Evaluation of the anti-diabetic potential of selected medicinal plant extracts from the Canadian Boreal Forest used to treat symptoms of diabetes: part II. Canadian Journal of Physiology and Pharmacology 2009, 87:479-492.
25. Helliwell P.A., Richardson M., Affleck J., Kellett G.L. Stimulation of fructose transport across the intestinal brush-border membrane by PMA is mediated by GLUT2 and dynamically regulated by protein kinase C. Biochemical Journal 2000, 350:149-154.
26. Hongu M., Funami N., Takahashi Y., Saito K., Arakawa K., Matsumoto M., Yamakita H., Tsujihara K. Na(+)-glucose cotransporter inhibitors as antidiabetic agents. III. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives modified at the OH groups of the glucose moiety. Chemical and Pharmaceutical Bulletin (Tokyo) 1998, 46:1545-1555.
27. Johnston K., Sharp P., Clifford M., Morgan L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Letters 2005, 579:1653-1657.
28. Keller D.M., Lotspeich W.D. Effect of phlorizin on the osmotic behavior of mitochondria in isotonic sucrose. Journal of Biological Chemistry 1959, 234:991-994.
29. Kellet G.L., Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 2005, 54:3056-3062.
30. Kellett G.L., Helliwell P.A. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush border membrane. Biochemical Journal 2000, 350:155-162.
31. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., Gary Williamson G. How should we assess the effects of exposure to dietary polyphenols in vitro?. The American Journal of Clinical Nutrition 2004, 80:21.
32. Kwon O., Eck P., Chen S., Corpe C.P., Lee J.H., Kruhlak M., Levine M. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB Journal 2007, 21:366-377.
33. Leduc C., Coonishish J., Haddad P., Cuerrier A. Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany. Journal of Ethnopharmacology 2006, 105:55-63.
34. Li J.M., Che C.T., Lau C.B.S., Leung P.S., Cheng C.H.K. Desoxyrhaponticin (3,5-Dihydroxy-4'-methoxystilbene 3-O-β-d-glucoside) inhibits glucose uptake in the intestine and kidney: in vitro and in vivo studies. Journal of Pharmacology and Experimental Therapeutics 2006, 320:38-46.
35. Mahraoui L., Rodolosse A., Barbat A., Dusaulx E., Zweibaum A., Rousset M., Brot-Laroche E. Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochemical Journal 1994, 298:629-633.
36. Malathi P., Crane R.K. Phlorizin hydrolase: a β-glucosidase of hamster intestinal brush border membrane. Biochimica et Biophysica Acta 1969, 173:245-256.
37. Marles R.J., Farnsworth N.R. Antidiabetic plants and their active constituents. Phytomedicine 1995, 2:137-189.
38. Meezan E., Meezan E.M., Jones K., Moore R., Barnes S., Prasain J.K. Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. Journal of Agricultural and Food Chemistry 2005, 53:8760-8767.
39. Ndong M., Uehara M., Katsumata S., Suzuki K. Effects of oral administration of Moringa oleifera Lam on glucose tolerance in Goto-Kakizaki and Wistar rats. Journal of Clinical Biochemistry and Nutrition 2007, 40:229-233.
40. Newey H., Parsons B.J., Smyth D.H. The Site of action of phlorizin in inhibiting intestinal absorption of glucose. Journal of Physiology 1959, 148:83-92.
41. Porte D., Schwartz M.W. Diabetes complications: why is glucose potentially toxic?. Science 1996, 272:699-700.
42. Prasain J.K., Barnes S. Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus. Molecular Pharmacology 2007, 4:846-864.
43. Song J., Kwon O., Chen S., Daruwala R., Eck P., Park J.B., Levine M. Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2). Intestinal transporters for vitamin C and glucose. The Journal of Biological Chemistry 2002, 277:15252-15260.
44. Spoor D.C., Martineau L.C., Leduc C., Benhaddou-Andaloussi A., Meddah B., Harris C., Burt A., Fraser M.H., Coonishish J., Joly E., Cuerrier A., Bennett S.A.L., Johns T., Prentki M., Arnason J.T., Haddad P.S. Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential. Canadian Journal of Physiology and Pharmacology 2006, 84:847-858.
45. Swanston-Flatt S.K., Day C., Flatt P.R., Bailey C.J. Evaluation of the antihyperglycaemic properties of traditional plant treatments for diabetes. Frontiers in Diabetes Research. Lessons from Animal Diabetes 1990, vol. 3:286-293. Smith-Gordon, London.
46. Thouez J.P., Ekoé J.M., Foggin P.M., Verdy M., Nadeau M., Laroche P., Rannou A., Ghadirian P. Obesity, hypertension, hyperuricemia and diabetes mellitus among the Cree and Inuit of northern Québec. Arctic Medical Research 1990, 49:180-188.
47. Tsujihara K., Hongu M., Saito K., Kawanishi H., Kuriyama K., Matsumoto M., Oku A., Ueta K., Tsuda M., Saito A. Na(+)-glucose cotransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring. Journal of Medicinal Chemistry 1999, 42:5311-5324.
48. Tsujihara K., Hongu M., Saito K., Inamasu M., Arakawa K., Oku A., Matsumoto M. Na(+)-glucose cotransporter inhibitors as antidiabetics. I. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives based on a new concept. Chemical and Pharmaceutical Bulletin (Tokyo) 1996, 44:1174-1180.
49. Verspohl E.J. Recommended testing in diabetes research. Planta Medica 2002, 68:581-590.
50. Vianna R., Brault A., Martineau L.C., Couture R., Arnasaon J.T., Haddad P.S. Extract of Sorbus decora (Mountain ash) bark exerts acute and chronic anti-hyperglycemic activity in diabetic mice and rats. Evidence Based Complementary and Alternative Medicine 2010, (e-publication ahead of print). 10.1093/ecam/nep158.
51. Vinson J.A., Zhang J. Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes. Journal of Agricultural and Food Chemistry 2005, 53:3710-3713.
52. +/glucose cotransporter. Annual Review of Physiology 1993, 55:575-589.
53. Young T.K., Reading J., Elias B., O'Neil J.D. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. Canadian Medical Association Journal 2000, 163:561-566.
54. Zimmet P.Z., McCarty D.J., DeCourten M.P. The global epidemiology of noninsulin dependent diabetes mellitus and the metabolic syndrome. Journal of Diabetes and its Complications 1997, 11:60-68.